Copyright
©The Author(s) 2021.
World J Crit Care Med. Jan 9, 2021; 10(1): 1-11
Published online Jan 9, 2021. doi: 10.5492/wjccm.v10.i1.1
Published online Jan 9, 2021. doi: 10.5492/wjccm.v10.i1.1
Figure 2 Respiratory management in coronavirus disease patients with pulmonary compromise.
Extracorporeal membrane oxygenation is reserved as a final resort when all other noninvasive and invasive ventilation options fail. SpO2: Saturation of oxygen via pulse oximetry; HFNC: High flow nasal cannula; BiPAP: Bilevel positive airway pressure; ET: Endotracheal; NMBA: Neuromuscular blockade agent; NIV: Noninvasive ventilation; IMV: Invasive mechanical ventilation; ECMO: Extracorporeal membrane oxygenation.
- Citation: Kichloo A, Kumar A, Amir R, Aljadah M, Farooqi N, Albosta M, Singh J, Jamal S, El-Amir Z, Kichloo A, Lone N. Utilization of extracorporeal membrane oxygenation during the COVID-19 pandemic. World J Crit Care Med 2021; 10(1): 1-11
- URL: https://www.wjgnet.com/2220-3141/full/v10/i1/1.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v10.i1.1